← FDA DRUG APPROVALS

FDA NDA · NDA050576

NILSTAT

Sponsor: STRIDES PHARMA INTL

APPLICATION
NDA050576
TYPE
NDA
ORIGINAL APPROVAL
1983-12-22
LATEST ACTION
1999-05-08
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

NILSTAT · ReferenceDiscontinued
NYSTATIN 100% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · POWDER · ORAL

Approval history

1999-05-08Manufacturing (CMC) · Supplement 2 · standardAP
1983-12-22Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →